ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,668Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 161

$699K Total Retail Price of All Prescriptions

Rank: 5 out of 161

2,676 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

30% of this provider’s 2,676 patients filled at least one prescription for a schedule two drug, compared to an average of 51%.

Schedule Three
Controlled Substances

33% of this provider’s 2,676 patients filled at least one prescription for a schedule three drug, compared to an average of 30%.

Risky Drugs to Seniors

1% of this provider’s 9,603 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

5 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
GABAPENTIN 2,957 2,456 10 1 2
HYDROCODONE-ACETAMINOPHEN 1,924 1,411 S3 2 1
MELOXICAM 1,190 1,018 3 15
TRAMADOL HCL 1,019 921 4 6
OXYCODONE HCL-ACETAMINOPHEN 916 442 S2 5 5
LYRICA 430 300 6 16
MORPHINE SULFATE ER 399 113 S2 7 4
OXYCODONE-ACETAMINOPHEN 396 292 S2 8 9
VOLTAREN 381 302 9 25
OXYCODONE HCL 366 77 S2 10 3
FENTANYL 299 211 S2 11 8
ENDOCET 273 100 S2 12 20
BUTRANS 266 260 S3 10 13 36
ACETAMINOPHEN-CODEINE 243 230 S3 14 29
BACLOFEN 232 142 15 18
NAPROXEN 228 161 16 27
OXYCONTIN 222 104 S2 17 11
ALPRAZOLAM 187 72 18 31
HYDROMORPHONE HCL 177 32 S2 19 14
CYMBALTA 164 110 20 22
LIDODERM 153 85 21 21
CELEBREX 122 111 22 30
DICLOFENAC SODIUM 81 72 23 26
OPANA ER 71 25 S2 24 33
TIZANIDINE HCL 67 20 25 12
CARISOPRODOL 64 13 R 26 10
CYCLOBENZAPRINE HCL 62 21 R 27 17
NORTRIPTYLINE HCL 60 55 28 42
MORPHINE SULFATE 59 0 S2 29 13
ZOLPIDEM TARTRATE 50 30 30 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.